A source-led Melanotan II 10 mg profile covering standardized peptide identity and the explicit FDA unapproved-drug and safety context.
PubChem lists Melanotan II as CID 92432, a synthetic cyclic heptapeptide analog of alpha-melanotropin, with molecular formula C50H69N15O9 and molecular weight about 1024.2 g/mol.1
Public regulatory material is especially important for this compound. FDA enforcement records describe Melanotan II as an unapproved new drug, and FDA compounding safety material also lists Melanotan II among substances that may present significant safety risks.23
Responsible organic positioning requires explicit unapproved-drug context rather than promotional tanning or therapeutic claims.
An FDA enforcement record describes Melanotan II as a peptide that had been marketed as an injectable tanning product and states that FDA considered it an unapproved new drug. The record also describes enforcement related to continued distribution.2
PubChem lists Melanotan II as CID 92432 and provides its cyclic peptide identity, molecular formula and molecular weight.1
FDA states that compounded Melanotan II may pose immunogenicity risk because of aggregation or peptide-related impurities.3
This page does not promote tanning, provide administration or dosing instructions, claim cancer prevention or rosacea treatment, or represent Melanotan II as an approved medicine.
MedCore Melanotan II is presented as a 10 mg research product. Any route, formulation, purity, batch or analytical information should be added only when directly supported by MedCore documentation.
No route of administration, clinical indication, purity or treatment claim is inferred from the product image or third-party literature.
Product-specific documentation can be added without weakening the page's explicit unapproved-drug and evidence boundaries.
Strength-specific documentation preview for the MedCore Melanotan II research presentation.
These images are presented as sample product documentation and should not be interpreted as independently verified analytical certification. Product identity, batch data and analytical claims should be checked against original laboratory records.
Related links support entity discovery without importing claims from unrelated peptides.
Short answers keep unapproved status and safety context visible instead of treating them as footer-only disclaimers.
The page relies on standardized chemical identity plus direct FDA regulatory and safety source material. Last reviewed 2 September 2026.
Standardized cyclic-peptide identity, formula and molecular weight.
Open PubChem source ↗FDA record describing Melanotan II as an unapproved new drug in an enforcement context.
Open FDA record ↗FDA safety context for compounded Melanotan II.
Open FDA source ↗Review the quality framework or contact MedCore for product-specific documentation.
